Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBMPG.L Regulatory News (BMPG)

  • There is currently no data for BMPG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

27 Jan 2020 07:00

RNS Number : 9183A
BMO Managed Portfolio Trust PLC
27 January 2020
 

To: RNS

Date: 27 January 2020

From: BMO Managed Portfolio Trust PLC

LEI: 213800ZA6TW45NM9YY31

 

 

 

Interim Results

The Board of BMO Managed Portfolio Trust PLC announces the unaudited interim results of the Company for the six month period to 30 November 2019.

 

Income shares - financial highlights and performance summary for the six months

·; Dividend yield(1) of 4.4% at 30 November 2019, compared to the yield on the FTSE All-Share Index of 4.2%. Dividends are paid quarterly. First two interim dividends increased by 3.7% compared to the prior year.

·; Net asset value total return(2) per Income share of +6.3% for the six months, outperforming the FTSE All-Share Index total return (+5.8%) by +0.5%.

 

Growth shares - financial highlights and performance summary for the six months

·; Net asset value total return(2) per Growth share of +4.6% for the six months, underperforming the FTSE All-Share Index total return (+5.8%) by -1.2%.

·; NAV total return Compound Annual Growth Rate of +10.3% over 10 years compared with a return of +8.2% from the FTSE All-Share Index.

 

Notes:

(1) Dividend yield - See Alternative Performance Measures. Based on dividends at the expected minimum annual rate of 6.1 pence per Income share for the financial year to 31 May 2020 and the Income share price of 137.50p at 30 November 2019.

(2) NAV total return - See Alternative Performance Measures. The return to shareholders calculated on a per share basis by adding dividends paid in the period to the increase or decrease in the NAV in the period. The dividends are assumed to have been re-invested in the form of net assets on the date on which shares were quoted ex-dividend.

 

 

Chairman's Statement

 

Highlights

Net asset value total return of +6.3% for the Income shares and +4.6% for the Growth shares compared to the FTSE All-Share Index total return of +5.8%

 

NAV total return compound annual growth rate over 10 years of +9.8% for the Income shares and +10.3% for the Growth shares compared with a return of +8.2% from the FTSE All-Share Index

 

First two interim dividends increased from 1.35 pence to 1.4 pence per Income share

 

Income share dividend yield of 4.4% at 30 November 2019

 

Investment performance

For the six months to 30 November 2019, the net asset value (NAV) total return was +6.3% for the Income shares and +4.6% for the Growth shares. The total return for the benchmark index for both portfolios, the FTSE All-Share Index, was +5.8%. The long-term track record continues to show the NAV total return for both portfolios outperforming the benchmark index over 3, 5 and 10 years to 30 November 2019, with NAV total return growth over 10 years achieving a compound annual return of +9.8% for the Income shares and +10.3% for the Growth shares.

 

In line with our stated objectives we have again been able to increase our interim dividends. At 30 November 2019 the dividend yield of the Income shares was 4.4% (based on the expected minimum annual dividend of 6.1 pence per Income share for the current financial year) as compared to the yield on the FTSE All-Share Index of 4.2%.

 

The period under review saw a decent positive return from the UK equity market however this masked some significant volatility caused by massive political uncertainty in the UK, particularly in the latter few months. A feature was sterling, which had been weak for a prolonged period, but then began to rise sharply in October as the likelihood of a "no deal Brexit" diminished. It ended the six months gaining 2.6% and 3.7% against the dollar and euro respectively, a marked change of trend for the currency.

 

Globally, concerns over prospects for growth led to three cuts in interest rates by the US Federal Reserve, a modest return to the policy of Quantitative Easing by the European Central Bank and a further stimulus package from the Bank of Japan.

 

Equity markets responded positively to these measures, although due to strength of the UK currency the returns from overseas markets were diluted when translated back into sterling. Against this background both portfolios made gains over the period with the Income portfolio slightly ahead and the Growth portfolio slightly behind the total return of the FTSE All-Share Index.

 

Once again, a theme amongst the top contributors to performance from individual holdings in the Growth portfolio was technology with HgCapital Trust and long-time holding Polar Capital Technology Trust experiencing share price gains of 19% and 16% respectively. The secular growth theme of healthcare saw the best performance with Biotech Growth Trust gaining 20% and Worldwide Healthcare Trust ahead by 17%.

 

In the Income portfolio the healthcare theme was also evident amongst the best performers with Swiss based HBM Healthcare Investments achieving a 21% rise in share price. Other top contributors were specialist healthcare property REIT Assura which rose 21% and consistent long-term outperformer Invesco Perpetual UK Smaller Companies Investment Trust whose share price gained 18%.

 

(All share prices are total return)

 

Revenue and dividends

The Company's net revenue for the six months was £1.50 million which is equivalent to 3.40p per Income share (compared to 3.27p per Income share for the corresponding period in 2018). Income shares are entitled to all the dividends paid by the Company.

 

In line with our objective of increasing dividends over time, the Company has declared a first and second interim dividend in respect of the year to 31 May 2020, each of 1.4p per Income share (1.35p per Income share in the corresponding period in the year to 31 May 2019).

 

In the absence of unforeseen circumstances, the Board intends to pay three interim dividends, each of 1.4p per Income share and the aggregate dividends for the current financial year to 31 May 2020 will be at least 6.1p per Income share (2019: 5.95p per Income share). The amount of the fourth interim dividend will be determined when a clearer view of income for the year emerges. A minimum expected annual rate of 6.1p per Income share represents a yield on the Income share price at 30 November 2019 of 4.4%.

 

Borrowing

At 30 November 2019 the Income portfolio had total borrowings of £5 million (7.6% of gross assets) the investment of which helps to boost net income after allowing for the interest cost. The Growth portfolio had no borrowings.

 

Discount to NAV and share buy-backs

In normal circumstances we aim to maintain our discount at not more than 5%, by buying back shares from time to time if necessary. In practice over the years the shares have generally traded close to NAV. During the six months to 30 November 2019 the average premium to NAV for the Income shares and for the Growth shares was 0.9% and 0.0% respectively. At 30 November 2019, the Income shares stood at a premium to NAV of 0.5% and the Growth shares at a discount of 0.8% to NAV.

 

Share conversion facility

Shareholders have the opportunity to convert their Income shares into Growth shares or their Growth shares into Income shares annually subject to minimum and maximum conversion thresholds which may be reduced or increased at the discretion of the Board. At the start of November 2019 the conversion proceeded, for those shareholders who had elected to do so. The ability to convert without incurring capital gains tax should be an attractive facility for shareholders and the next conversion date (subject to minimum and maximum thresholds) will be in October 2020. Details will be provided when the Company's annual report is published in late July 2020.

 

Outlook

It appears the actions taken by the US Federal Reserve and other central banks has had the desired effect and prospects for growth in 2020 have modestly improved such that the economic cycle appears likely to be extended and the chances of a recession pushed out until 2021 at the earliest. Whilst for most developed countries growth remains moderate by historic standards, inflation is subdued and interest rates will remain low. This is an encouraging backdrop for equity markets. Since the end of the period under review much has changed for the UK and following a decisive general election it appears the uncertainty caused by Brexit is likely to wane. Post the Brexit Referendum in 2016 the UK equity market has been out of favour with global institutions and has underperformed most other major markets. The UK equity market offers very attractive value not only relative to other global equity markets but also in a historical context. In this regard smaller companies or those with mainly domestic revenues could benefit most from a reduction of uncertainty and perhaps slightly better growth from the UK economy. Since the end of the period under review both new and existing holdings which have significant exposure in the areas identified above have either been introduced or increased.

 

Looking forward there are certain factors which could unsettle markets: China/US trade tensions being unresolved, or an EU/UK trade deal not being concluded. However, should the policy adopted by monetary authorities continue in the same vein, then that provides a positive background for equity markets to make modest progress.

 

 

 

Colin S McGill

Chairman

24 January 2020

 

Unaudited Condensed Income Statement

Six months to 30 November 2019

Notes

Revenue

Capital

Total

£'000

£'000

£'000

Gains on investments

-

5,852

5,852

Foreign exchange losses

-

(1)

(1)

Income

2

1,927

-

1,927

Investment management and performance fees

3

(130)

(342)

(472)

Other expenses

(272)

-

(272)

Return on ordinary activities before

finance costs and tax

 

1,525

 

5,509

 

7,034

Finance costs

(22)

(33)

(55)

Return on ordinary activities before tax

1,503

5,476

6,979

Tax on ordinary activities

-

-

-

Return attributable to shareholders

1,503

5,476

6,979

Return per Income share

5

3.40p

4.80p

8.20p

Return per Growth share

5

-

9.44p

9.44p

 

The total column of this statement is the Profit and Loss Account of the Company.

 

The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.

 

All revenue and capital items in the Income Statement derive from continuing operations.

 

Unaudited Condensed Income Statement

Six months to 30 November 2018

 

Notes

Revenue

Capital

Total

£'000

£'000

£'000

Losses on investments

Foreign exchange losses

-

-

(4,747)

(2)

(4,747)

(2)

Income

2

1,822

-

1,822

Investment management and performance fees

3

(124)

(492)

(616)

Other expenses

(260)

-

(260)

Return on ordinary activities before finance costs and tax

 

1,438

 

(5,241)

 

(3,803)

Finance costs

(22)

(33)

(55)

Return on ordinary activities before tax

1,416

(5,274)

(3,858)

Tax on ordinary activities

(7)

-

(7)

Return attributable to shareholders

1,409

(5,274)

(3,865)

Return per Income share

5

3.27p

(6.32p)

(3.05p)

Return per Growth share

5

-

(7.20p)

(7.20p)

 

The total column of this statement is the Profit and Loss Account of the Company.

 

The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.

 

All revenue and capital items in the Income Statement derive from continuing operations.

Condensed Income Statement (audited)

Year to 31 May 2019

Notes

Revenue

Capital

Total

£'000

£'000

£'000

Losses on investments

-

(880)

(880)

Foreign exchange losses

-

(8)

(8)

Income

2

3,655

-

3,655

Investment management and performance fees

3

(252)

(940)

(1,192)

Other expenses

(495)

-

(495)

Return on ordinary activities before

finance costs and tax

 

2,908

 

(1,828)

 

1,080

 

Finance costs

(44)

(65)

(109)

Return on ordinary activities before tax

2,864

(1,893)

971

Tax on ordinary activities

(24)

-

(24)

Return attributable to shareholders

2,840

(1,893)

947

Return per Income share

5

6.59p

(3.47p)

3.12p

Return per Growth share

5

-

(1.12p)

(1.12p)

 

 

 

The total column of this statement is the Profit and Loss Account of the Company.

 

The supplementary revenue and capital columns are prepared under guidance published by The Association of Investment Companies.

 

All revenue and capital items in the Income Statement derive from continuing activities.

 

 

Unaudited Condensed Balance Sheet

As at 30 November 2019

Notes

Income

Shares

Growth

Shares

 

Total

£'000

£'000

£'000

Fixed assets

Investments

4

64,170

71,939

136,109

Current assets

Debtors

252

81

333

Cash at bank and on deposit

1,860

4,543

6,403

2,112

4,624

6,736

Creditors:

Amounts falling due within one year

 

 

 

(311)

 

(453)

 

(764)

Net current assets

1,801

4,171

5,972

Creditors:

Amounts falling due in more than one year

 

(5,000)

 

-

 

(5,000)

Net assets

60,971

76,110

137,081

Capital and reserves:

Called-up share capital

7

4,457

3,558

8,015

Share premium

25,082

21,726

46,808

Capital redemption reserve

54

206

260

Special Reserve

18,745

16,435

35,180

Capital reserves

10,040

34,185

44,225

Revenue reserve

2,593

-

2,593

Shareholders' funds

60,971

76,110

137,081

Net asset value per share (pence)

8

136.75p

214.62p

 

 

Unaudited Condensed Balance Sheet

As at 30 November 2018

 

Notes

Income shares

Growth shares

 

Total

 

£'000

£'000

£'000

Fixed assets

Investments

58,295

67,693

125,988

Current assets

Debtors

Cash at bank and on deposit

245

1,750

83

3,481

328

5,231

1,995

3,564

5,559

Creditors

Amounts falling due within one year

(220)

(307)

(527)

Net current assets

1,775

3,257

5,032

Creditors

Amounts falling due in more than one year

(5,000)

-

(5,000)

Net assets

55,070

70,950

126,020

Capital and reserves

Called-up share capital

4,298

3,564

7,862

Share premium

22,718

21,409

44,127

Capital redemption reserve

24

185

209

Special reserve

19,066

17,117

36,183

Capital reserves

6,693

28,675

35,368

Revenue reserve

2,271

-

2,271

Shareholders' Funds

55,070

70,950

126,020

Net asset value per share (pence)

8

128.31p

199.11p

 

Condensed Balance Sheet (audited)

As at 31 May 2019

 

Income shares

Growth shares

 

Total

Notes

£'000

£'000

£'000

Fixed assets

Investments

4

61,321

68,943

130,264

Current assets

Debtors

292

47

339

Cash at bank and on deposit

1,256

4,571

5,827

1,548

4,618

6,166

Creditors

Amounts falling due within one year

(241)

(191)

(432)

Net current assets

1,307

4,427

5,734

Creditors

Amounts falling due in more than one year

(5,000)

(257)

(5,257)

Net assets

57,628

73,113

130,741

Capital and reserves

Called-up share capital

4,372

3,563

7,935

Share premium

23,703

21,417

45,120

Capital redemption reserve

30

186

216

Special reserve

19,066

17,117

36,183

Capital reserves

7,919

30,830

38,749

Revenue reserve

2,538

-

2,538

Shareholders' Funds

57,628

73,113

130,741

Net asset value per share (pence)

8

131.81p

205.17p

 

Unaudited Condensed Statement of Cash Flows

Six months to 30 November 2019

 

 

Notes

Income shares

Growth shares

 

Total

£'000

£'000

£'000

Net cash outflow from operations before dividends and interest

 

 9

 

(387)

 

(388)

 

(775)

Dividends received

1,431

474

1,905

Interest received

4

12

16

Interest paid

(51)

-

(51)

Net cash inflow from operating activities

997

98

1,095

Investing activities

Purchases of investments

(1,606)

(301)

(1,907)

Sales of investments

1,494

533

2,027

Cash flows from investing activities

(112)

232

120

Cash flows before financing activities

885

330

1,215

Financing activities

Equity dividends paid

Net proceeds from issuance of new shares

6

(1,448)

1,081

-

-

(1,448)

1,081

Sale of shares from treasury

-

150

150

Shares purchased to be held in treasury

-

(422)

(422)

Share conversion

86

(86)

-

Cash flows from financing activities

(281)

(358)

(639)

Net movement in cash and cash equivalents

604

(28)

576

Cash and cash equivalents at the beginning of the period

 

1,256

 

4,571

 

5,827

Cash and cash equivalents at the end of the period

 

1,860

 

4,543

 

6,403

Represented by:

Cash at bank and short-term deposits

 

1,860

 

4,543

 

6,403

Unaudited Condensed Statement of Cash Flows

Six months to 30 November 2018

 

 

Notes

Income shares

Growth shares

 

Total

£'000

£'000

£'000

Net cash outflow from operations before dividends and interest

 

9

 

(313)

 

(634)

 

(947)

Dividends received

1,289

493

1,782

Interest received

3

5

8

Interest paid

(52)

-

(52)

Net cash inflow/ (outflow) from operating activities

927

(136)

791

Investing activities

Purchases of investments

(2,324)

(5,819)

(8,143)

Sales of investments

3,110

5,261

8,371

Cash flows from investing activities

786

(558)

228

Cash flows before financing activities

1,713

(694)

1,019

Financing activities

Equity dividends paid

Net proceeds from issuance of new shares

6

(1,700)

64

-

746

(1,700)

810

Share conversion

(232)

232

-

Cash flows from financing activities

(1,868)

978

(890)

Net movement in cash and cash equivalents

(155)

284

129

Cash and cash equivalents at the beginning of the period

 

1,905

 

3,197

 

5,102

Cash and cash equivalents at the end of the period

 

1,750

 

3,481

 

5,231

Represented by:

Cash at bank and short-term deposits

 

1,750

 

3,481

 

5,231

 

 

 

 

Condensed Statement of Cash Flows (audited)

Year to 31 May 2019

 

 

 

 

Notes

Income shares

Growth shares

 

Total

£'000

£'000

£'000

Net cash outflow from operations before dividends and interest

 

9

 

(624)

 

(984)

 

(1,608)

Dividends received

2,574

1,002

3,576

Interest received

9

20

29

Interest paid

(102)

-

(102)

Net cash inflow from operating activities

1,857

38

1,895

Investing activities

Purchases of investments

(5,607)

(7,408)

(13,015)

Sales of investments

5,068

7,758

12,826

Cash flows from investing activities

(539)

350

(189)

Cash flows before financing activities

1,318

388

1,706

Financing activities

Equity dividends paid

6

(2,864)

-

(2,864)

Net proceeds from issue of new shares

Sale of shares from treasury

1,129

-

746

157

1,875

157

Shares purchased to be held in treasury

-

(149)

(149)

Share conversion

(232)

232

-

Cash flows from financing activities

(1,967)

986

(981)

Net movement in cash and cash equivalents

(649)

1,374

725

Cash and cash equivalents at the beginning of the year

 

1,905

 

3,197

 

5,102

Cash and cash equivalents at the end of the year

 

1,256

 

4,571

 

5,827

Represented by:

Cash at bank and short-term deposits

 

1,256

 

4,571

 

5,827

 

 

Unaudited Condensed Statement of Changes in Equity

Six months to 30 November 2019

 

 

 

 

Income shares

 

Share capital

£000

Share premium account

£000

Capital redemption reserve

£000

 

Special reserve

£000

 

Capital reserves

£000

 

Revenue reserve

£000

Total shareholders' funds

£000

As at 31 May 2019

4,372

23,703

30

19,066

7,919

2,538

57,628

Increase in share capital in issue, net of share issuance expenses

 

 

 

80

 

 

 

1,001

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,081

Share conversion

5

378

24

(321)

-

-

86

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

321

 

 

321

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(321)

 

 

-

 

 

(321)

Dividends paid

-

-

-

-

-

(1,448)

(1,448)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

2,442

 

1,182

 

3,624

As at 30 November 2019

 

4,457

 

25,082

 

54

 

18,745

 

10,040

 

2,593

 

60,971

Growth shares

As at 31 May 2019

3,563

21,417

186

17,117

30,830

-

73,113

Shares sold from treasury

 

-

 

3

 

-

 

147

 

-

 

-

 

150

Shares purchased for treasury

 

-

 

-

 

-

 

(422)

 

-

 

-

 

(422)

Share conversion

(5)

306

20

(407)

-

-

(86)

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(321)

 

 

(321)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

321

 

 

-

 

 

321

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

3,034

 

321

 

3,355

As at 30 November 2019

 

3,558

 

21,726

 

206

 

16,435

 

34,185

 

-

 

76,110

 

Total Company

As at 31 May 2019

7,935

45,120

216

36,183

38,749

2,538

130,741

Increase in share capital in issue, net of share issuance expenses

 

 

 

80

 

 

 

1,001

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,081

Shares sold from treasury

 

-

 

3

 

-

 

147

 

-

 

-

 

150

Shares purchased for treasury

 

-

 

-

 

-

 

(422)

 

-

 

-

 

(422)

Share conversion

-

684

44

(728)

-

-

-

Dividends paid

-

-

-

-

-

(1,448)

(1,448)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

5,476

 

1,503

 

6,979

Total Company as at 30 November 2019

 

8,015

 

46,808

 

260

 

35,180

 

44,225

 

2,593

 

137,081

Unaudited Condensed Statement of Changes in Equity

Six months to 30 November 2018

 

 

 

 

 

Income shares

 

Share capital

£000

Share premium account

£000

Capital redemption reserve

£000

 

Special reserve

£000

 

Capital reserves

£000

 

Revenue reserve

£000

Total shareholders' funds

£000

As at 31 May 2018

4,306

22,597

-

19,371

9,414

2,562

58,250

Increase in share capital in issue, net of issuance expenses

 

5

 

59

 

-

 

-

 

-

 

-

 

64

Share conversion

(13)

62

24

(305)

-

-

(232)

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

333

 

 

333

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(333)

 

 

-

 

 

(333)

Dividends paid

-

-

-

-

-

(1,700)

(1,700)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

(2,388)

 

1,076

 

(1,312)

As at 30 November 2018

 

4,298

 

22,718

 

24

 

19,066

 

6,693

 

2,271

 

55,070

Growth shares

As at 31 May 2018

3,517

20,408

182

17,190

31,228

-

72,525

Increase in share capital in issue, net of share issuance expenses

 

 

 

34

,

 

 

712

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

746

Share conversion

13

289

3

(73)

-

-

232

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(333)

 

 

(333)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

333

 

 

-

 

 

333

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

(2,886)

 

333

 

(2,553)

As at 30 November 2018

 

3,564

 

21,409

 

185

 

17,117

 

28,675

 

-

 

70,950

 

Total Company

 

As at 31 May 2018

 

7,823

 

43,005

 

182

 

36,561

 

40,642

 

2,562

 

130,775

Share conversion

-

351

27

(378)

-

-

-

Increase in share capital in issue, net of share issuance expenses

 

 

 

39

 

 

 

771

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

810

Dividends paid

-

-

-

-

-

(1,700)

(1,700)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

(5,274)

 

1,409

 

(3,865)

Total Company

as at 30 November 2018

 

 

7,862

 

 

44,127

 

 

209

 

 

36,183

 

 

35,368

 

 

2,271

 

 

126,020

 

Condensed Statement of Changes in Equity (audited)

Year to 31 May 2019

 

 

 

 

Income Shares

 

Share capital

£000

Share premium account

£000

Capital redemption reserve

£000

 

Special reserve

£000

 

Capital reserves

£000

 

Revenue reserve

£000

Total shareholders' funds

£000

As at 31 May 2018

4,306

22,597

-

19,371

9,414

2,562

58,250

Increase in share capital in issue, net of share issuance expenses

 

 

85

 

 

1,044

 

 

-

 

 

-

 

 

-

 

 

-

 

 

1,129

Share conversion

(13)

62

24

(305)

-

-

(232)

Cancellation of deferred shares

 

(6)

 

-

 

6

 

-

 

-

 

-

 

-

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

646

 

 

646

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(646)

 

 

-

 

 

(646)

Dividends paid

-

-

-

-

-

(2,864)

(2,864)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

(849)

 

2,194

 

1,345

As at 31 May 2019

4,372

23,703

30

19,066

7,919

2,538

57,628

Growth Shares

As at 31 May 2018

3,517

20,408

182

17,190

31,228

-

72,525

Increase in share capital in issue, net of share issuance expenses

 

 

34

 

 

712

 

 

-

 

 

-

 

 

-

 

 

-

 

 

746

Shares sold from treasury

 

-

 

8

 

-

 

149

 

-

 

-

 

157

Shares purchased for treasury

 

-

 

-

 

-

 

(149)

 

-

 

-

 

(149)

Share conversion

13

289

3

(73)

-

-

232

Cancellation of deferred shares

 

(1)

 

-

 

1

 

-

 

-

 

-

 

-

Transfer of net income from Growth to Income portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

-

 

 

(646)

 

 

(646)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

-

 

 

-

 

 

-

 

 

646

 

 

-

 

 

646

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

(1,044)

 

646

 

(398)

As at 31 May 2019

3,563

21,417

186

17,117

30,830

-

73,113

Total Company

As at 31 May 2018

7,823

43,005

182

36,561

40,642

2,562

130,775

Increase in share capital in issue, net of share issuance expenses

 

 

119

 

 

1,756

 

 

-

 

 

-

 

 

-

 

 

-

 

 

1,875

Shares sold from treasury

 

-

 

8

 

-

 

149

 

-

 

-

 

157

Shares purchased for treasury

 

-

 

-

 

-

 

(149)

 

-

 

-

 

(149)

Share conversion

-

351

27

(378)

-

-

-

Cancellation of deferred shares

 

(7)

 

-

 

7

 

-

 

-

 

-

 

-

Dividends paid

-

-

-

-

-

(2,864)

(2,864)

Return attributable to shareholders

 

-

 

-

 

-

 

-

 

(1,893)

 

2,840

 

947

Total Company as at 31 May 2019

 

7,935

 

45,120

 

216

 

36,183

 

38,749

 

2,538

 

130,741

Statement of Principal Risks and Uncertainties

 

Most of the Company's principal risks and uncertainties that could threaten the achievement of its objective; strategy, future performance, liquidity and solvency are market related and comparable to those of other investment trusts investing primarily in listed securities.

 

These risks, and the way in which they are managed, are described in more detail under the heading "Principal Risks and Uncertainties and Viability Statement" within the Strategic Report in the Company's 2019 Annual Report.

 

The Company's principal risks and uncertainties have not changed materially since the date of that report and are not expected to change materially for the remainder of the Company's financial year.

 

The most important types of risk associated with financial instruments are credit risk, market price risk, liquidity risk, interest rate risk and foreign currency risk. Other risks faced by the Company include investment, custody and operational risks. These include risks in relation to failures at service providers or loss or sabotage of data through cyber threats or business continuity failure.

 

 

 

Statement of Directors' Responsibilities in Respect of the Interim Report

 

We confirm, that to the best of our knowledge:

 

·; the condensed set of financial statements have been prepared in accordance with applicable UK Accounting Standards on a going concern basis and give a true and fair view of the assets, liabilities, financial position and return of the Company;

 

·; the Chairman's Statement and the Statement of Principal Risks and Uncertainties (together constituting the Interim Management Report) include a fair review of the information required by the Disclosure Guidance and Transparency Rules ('DTR') 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the financial statements;

 

·; the Statement of Principal Risks and Uncertainties shown above is a fair review of the principal risks and uncertainties for the remainder of the financial year; and

 

·; the Interim Report includes a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during the period, and any changes in the related party transactions described in the last Annual Report that could do so.

 

 

 

On behalf of the Board

 

Colin S McGill

Director

24 January 2020

 

 

Notes

 

1. Accounting policies

The condensed financial statements have been prepared on a going concern basis in accordance with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority, FRS 102, FRS 104 Interim Financial Reporting and the Statement of Recommended Practice ("SORP") "Financial Statements of Investment Trust Companies and Venture Capital Trusts" issued by The Association of Investment Companies ("AIC").

 

The accounting policies applied for the condensed financial statements are set out in the Company's annual report for the year ended 31 May 2019.

 

2. Income

Six months to

30 November 2019

Six months to

30 November 2018

Year to

31 May

2019

£'000

£'000

£'000

UK dividends

1,285

1,174

2,401

Overseas dividends

626

640

1,225

Deposit income

16

8

29

Total income

1,927

1,822

3,655

 

3. Investment management and performance fees

During the period, the Company incurred investment management fees of £447,000 (30 November 2018: £443,000; 31 May 2019: £862,000) of which £222,000 was payable to BMO Investment Business Limited at the period end.

At 30 November 2019 the adjusted total return of the Income portfolio for the period since 31 May 2019 (being the date a performance fee was last payable) exceeded that of the FTSE All-Share Index and a performance fee of £25,000 was accrued in the Income portfolio at 30 November 2019 (30 November 2018: £60,000; 31 May 2019: £73,000).

 

At 30 November 2019 the adjusted total return of the Growth portfolio since 31 May 2019 (being the date a performance fee was last recognised) did not exceed that of the FTSE All-Share Index and no performance fee has been recognised (30 November 2018: £113,000; 31 May 2019: £257,000).

 

As the NAV per Growth share at 31 May 2019 was less than the Watermark NAV at 31 May 2018 (the date a performance fee was last payable in the Growth portfolio) payment of the performance fee of £257,000 which was accrued in the Growth portfolio at 31 May 2019 is deferred until the end of the next financial year when the NAV per share for the Growth portfolio is in excess of the Watermark NAV. If the Watermark NAV is not reached by the end of the fourth financial year subsequently, it will no longer be payable.

 

 

4. Investments

Income shares

Level 1*

£'000

Growth shares

Level 1*

£'000

 

 

Total

£'000

Cost at 31 May 2019

Gains at 31 May 2019

48,418

12,903

44,584

24,359

93,002

37,262

Valuation at 31 May 2019

Movement in the period:

Purchases at cost

Sales proceeds

Gains on investments sold in the period

Gains on investments held at period end

61,321

 

1,720

(1,494)

133

2,490

68,943

 

301

(533)

227

3,001

130,264

 

2,021

(2,027)

360

5,491

Valuation of investments held at 30 November 2019

 

64,170

 

71,939

 

136,109

 

Income shares

Level 1*

£'000

Growth shares

Level 1*

£'000

 

 

Total

£'000

Cost at 30 November 2019

Gains at 30 November 2019

48,777

15,393

44,579

27,360

93,356

42,753

Valuation at 30 November 2019

64,170

71,939

136,109

 

* Fair value hierarchy

The Company's investments as disclosed in the balance sheet are valued at fair value. The fair value as at the reporting date has been estimated using the following fair value hierarchy:

 

·; Level 1 - quoted prices (unadjusted) in active markets for identical assets;

·; Level 2 - investments whose value is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique whose variables includes only data from observable markets; and

·; Level 3 - investments whose value is not based on observable market data.

 

There were no investments held which are valued in accordance with levels 2 or 3.

 

5. Return per share

The return per share for the six months to 30 November 2019 is as follows:

 

Income shares

Growth shares

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

Return attributable to portfolios

 

1,182

 

2,442

 

3,624

 

321

 

3,034

 

3,355

Transfer of net income from Growth to Income portfolio

 

 

321

 

 

-

 

 

321

 

 

(321)

 

 

-

 

 

(321)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

(321)

 

 

(321)

 

 

-

 

 

321

 

 

321

Return attributable to shareholders

 

1,503

 

2,121

 

3,624

 

-

 

3,355

 

3,355

Return per share

3.40p

4.80p

8.20p

-

9.44p

9.44p

Weighted average number of shares in issue during the period

 

 

44,164,590

 

 

35,522,627

 

 

The return per share for the comparative six months to 30 November 2018 is as follows:

 

Income shares

Growth shares

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

Return attributable to portfolios

 

1,076

 

(2,388)

 

(1,312)

 

333

 

(2,886)

 

(2,553)

Transfer of net income from Growth to Income portfolio

 

 

333

 

 

-

 

 

333

 

 

(333)

 

 

-

 

 

(333)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

(333)

 

 

(333)

 

 

-

 

 

333

 

 

333

 Return attributable to shareholders

 

1,409

 

(2,721)

 

(1,312)

 

-

 

(2,553)

 

(2,553)

Return per share

3.27p

(6.32p)

(3.05p)

-

(7.20p)

(7.20p)

Weighted average number of shares in issue during the period

 

 

43,025,637

 

 

35,465,599

 

 

 

The return per share for the comparative year to 31 May 2019 is as follows:

 

Income shares

Growth shares

Revenue

Capital

Total

Revenue

Capital

Total

£'000

£'000

£'000

£'000

£'000

£'000

Return attributable to portfolios

 

2,194

 

(849)

 

1,345

 

646

 

(1,044)

 

(398)

Transfer of net income from Growth to Income portfolio

 

 

646

 

 

-

 

 

646

 

 

(646)

 

 

-

 

 

(646)

Transfer of capital from Income to Growth portfolio

 

 

-

 

 

(646)

 

 

(646)

 

 

-

 

 

646

 

 

646

 Return attributable to shareholders

 

2,840

 

(1,495)

 

1,345

 

-

 

(398)

 

(398)

Return per share

6.59p

(3.47p)

3.12p

-

(1.12p)

(1.12p)

Weighted average number of shares in issue during the period

 

 

43,089,136

 

 

35,541,265

 

 

6. Dividends

 

 

 

 

 

Payment

Six months to

30 November

2019

Six months to

30 November

2018

Year to

31 May

2019

Dividends on Income shares

Date

£'000

£'000

£'000

Amounts recognised as distributions during the period:

 

In respect of the previous financial year:

 - fourth interim of 1.90p (prior period: 1.80p) per share

 

12 Jul-2019

 

831

 

775

 

775

- special dividend of nil (prior period: 0.8p) per share

 

 

 

-

 

344

 

344

In respect of the period under review:

- first interim of 1.40p (prior period: 1.35p) per share

 

11 Oct 2019

 

617

 

581

 

581

- second interim (prior period: 1.35p per share)

 

-

 

-

 

-

 

580

- third interim (prior period: 1.35p per share)

 

-

 

-

 

-

 

584

1,448

1,700

2,864

 

A second interim dividend in respect of the year to 31 May 2020 of 1.4p per Income share was paid on 10 January 2020 to shareholders on the register on 20 December 2019. This amount has not been accrued in the results for the six months to 30 November 2019.

For the financial year to 31 May 2019 interim dividends totalled 5.95p per Income share.

 

The Growth shares do not carry an entitlement to receive dividends.

 

7. Share capital

Listed

Held in treasury

In issue

Number

£'000

Number

£'000

Number

£'000

Income shares

Balance at 1 June 2019 of

10p each

 

43,720,705

 

4,372

 

-

 

-

 

43,720,705

 

4,372

Issued

800,000

80

-

-

800,000

80

Share conversion:

- Income to Growth

(240,482)

(24)

-

-

(240,482)

(24)

- Growth to Income

305,314

29

-

-

305,314

29

- Change in nominal value^

-

(222)

-

-

-

(222)

Balance at 30 November 2019^

44,585,537

4,235

-

-

44,585,537

4,235

 

Deferred shares -

Income

Number

£'000

Deferred shares - Income

Balance at 1 June 2019

-

-

Issue of 44,280,223 shares*

44,280,223

222

Balance at 30 November 2019

44,280,223

222

Total called-up share capital

4,457

 

^ As part of the conversion process, which was carried out during the period in accordance with the Company's

Articles, the nominal value of each Income share changed from £0.1 to £0.094976101 per Income share.

* The nominal value of a deferred share is £0.005023899 per share.

 

During the period, the Company issued 800,000 Income shares from the block listing facilities receiving net proceeds of £1,081,000. At 30 November 2019, the Company held no Income shares in treasury.

 

During the period, valid conversion notices were received to convert 240,482 Income shares (which represented a value of £321,000). These were converted into 154,747 Growth shares in accordance with the Company's Articles and by reference to the ratio of the relative underlying net asset values of the Growth shares and Income shares on the conversion date.

 

The Company's Articles allow for Deferred shares to be allotted as part of the share conversion to

ensure that the conversion does not result in a reduction of the aggregate par value of the Company's issued share capital. The Deferred shares issued as part of the share conversion in the current period are set out above. The Deferred shares will be repurchased by the Company from time to time as authorised by shareholders at the September 2019 AGM.

 

 

Listed

Held in treasury

In issue

Number

£'000

Number

£'000

Number

£'000

Growth shares

Balance at 1 June 2019 of

10p each

35,634,929

3,563

-

-

35,634,929

3,563

Purchased for treasury

-

-

(200,000)

(20)

(200,000)

(20)

Resold from treasury

-

-

70,000

7

70,000

7

Share conversion:

- Income to Growth

(196,466)

(20)

-

-

(196,466)

(20)

- Growth to Income

154,747

15

-

-

154,747

15

- Change in nominal value^

-

(178)

-

1

-

(177)

Balance at

30 November 2019^

 

35,593,210

 

3,380

 

(130,000)

 

(12)

 

35,463,210

 

3,368

 

Deferred shares -

Growth

Number

£'000

Deferred shares - Growth

Balance at 1 June 2019

-

-

Issue of 35,438,463 shares*

35,438,463

178

Balance at 30 November 2019

35,438,463

178

Total called-up share capital

3,558

 

^ As part of the conversion process, which was carried out during the period in accordance with the Company's

Articles, the nominal value of each Growth share changed from £0.1 to £0.094976101 per Growth share.

* The nominal value of a deferred share is £0.005023899 per share.

 

During the period the Company bought back 200,000 (30 November 2018: nil; 31 May 2019: 75,000)

Growth shares to be held in treasury and resold out of treasury 70,000 (30 November 2018: nil; 31 May 2019: 75,000) Growth shares. At 30 November 2019, the Company held 130,000 Growth shares in treasury.

 

During the period, valid conversions were received to convert 196,466 Growth shares (which represented a value of £407,000). These were converted into 305,314 Income shares in accordance with the Company's Articles and by reference to the ratio of the relative underlying net asset values of the Growth shares and Income shares on the conversion date.

 

The Company's Articles allow for Deferred shares to be allotted as part of the share conversion to

ensure that the conversion does not result in a reduction of the aggregate par value of the Company's issued share capital. The Deferred shares issued as part of the share conversion in the current period are set out above. The Deferred shares will be repurchased by the Company from time to time as authorised by shareholders at the September 2019 AGM.

 

 

 

8. Net asset value per share

30 November

2019

30 November

2018

31 May

2019

Income shares

Net asset value per share - pence

136.75p

128.31p

131.81p

Net assets attributable at end of

period - £'000s

 

60,971

 

55,070

 

57,628

Shares in issue at end of period - number

44,585,537

42,920,705

43,720,705

Growth shares

Net asset value per share - pence

214.62p

199.11p

205.17p

Net assets attributable at end of

period - £'000s

 

76,110

 

70,950

 

73,113

Shares in issue at end of period - number

35,463,210

35,634,929

35,634,929

 

9. Reconciliation of return on ordinary activities before tax to net cash flows from operating activities

 

 

Six months to 30 November 2019

 

Income shares

£'000

 

 Growth shares

£'000

 

Total

£'000

Return on ordinary activities before tax

Adjust for returns from non-operating activities:

3,624

 

 

3,355

6,979

Gains on investments

(2,624)

(3,228)

(5,852)

Exchange losses

1

-

1

Return from operating activities

1,001

127

1,128

Increase in prepayments

-

(4)

(4)

(Decrease)/increase in creditors

(45)

5

(40)

Withholding tax recovered

13

-

13

Dividend income

(1,407)

(504)

(1,911)

Interest income

(4)

(12)

(16)

Interest expense

55

-

55

Net cash outflow from operations before dividends and interest

 

(387)

 

(388)

 

(775)

 

 

 

Six months to 30 November 2018

 

Income shares

£'000

 

 Growth shares

£'000

 

Total

£'000

Return on ordinary activities before tax

Adjust for returns from non-operating activities:

(1,308)

 

 

(2,550)

(3,858)

Losses on investments

2,174

2,573

4,747

Exchange losses

2

-

2

Return from operating activities

868

23

891

Decrease in prepayments

6

10

16

Increase/(decrease) in creditors

48

(135)

(87)

Withholding tax recovered/(suffered)

3

(3)

-

Dividend income

(1,290)

(524)

(1,814)

Interest income

(3)

(5)

(8)

Interest expense

55

-

55

Net cash outflow from operations before dividends and interest

 

(313)

 

(634)

 

(947)

 

 

 

 

 

 

 

 

 

 

 

Year to 31 May 2019

 

 

Income shares

£'000

 

 

Growth shares

£'000

 

 

Total

£'000

Return on ordinary activities before tax

Adjust for returns from non-operating activities:

1,366

 

 

(395)

971

Losses on investments

465

415

880

Exchange losses

8

-

8

Return from operating activities

1,839

20

1,859

Decrease in prepayments

9

13

22

Increase in creditors

71

6

77

Withholding tax suffered

(17)

(3)

(20)

Dividend income

(2,626)

(1,000)

(3,626)

Interest income

(9)

(20)

(29)

Interest expense

109

-

109

Net cash outflow from operations before dividends and interest

 

(624)

 

(984)

 

(1,608)

 

 

10. Earnings

Earnings for the six months to 30 November 2019 should not be taken as a guide to the results of the full year to 31 May 2020.

 

11. Tax

The effective revenue tax rate for the period to 30 November 2019 is nil % (30 November 2018: 0.5%; 31 May 2019: 0.8%). This is lower than the rate of corporation tax for small companies due to the level of non-taxable dividend income.

 

12. Bank borrowing

The Company has a £5 million fixed term loan to 10 February 2022 with The Royal Bank of Scotland International Limited. £5 million of the fixed term loan was drawn down as at 30 November 2019 at a fixed interest rate of 2.03% per annum.

 

13. Going concern

In assessing the going concern basis of accounting, the Directors have had regard to the guidance issued by the Financial Reporting Council and have undertaken a rigorous review of the Company's ability to continue as a going concern. As part of that review, the Board considered a range of Brexit scenarios and their probable implications for the Company's two investment portfolios.

 

The Company's investment objective and policy, which is subject to regular Board monitoring processes, is designed to ensure that the Company is invested principally in listed securities. The Company retains title to all assets held by its custodian and has an agreement relating to its borrowing facility with which it has complied. Cash is only held with banks approved and regularly reviewed by the Manager.

 

The Directors believe, in light of the controls and review processes and bearing in mind the nature of the Company's business and assets and revenue and expenditure projections, that the Company has adequate resources to continue in operational existence within its stated investment policy for a period of at least twelve months commencing from the date of approval of the financial statements. Accordingly, the financial statements have been drawn up on the basis that the Company is a going concern.

 

The Company does not have a fixed life, however, the Company's Articles of Association require the Board to put a resolution to shareholders at every fifth AGM to continue the Company. An ordinary resolution to approve the continuation of the Company was passed at the AGM held on 19 September 2018 and will next be put to shareholders at the AGM in 2023.

 

14. Related party transactions

The Directors of the Company are considered a related party. There have been no transactions with related parties during the first six months of the current financial year that have materially affected the financial position or performance of the Company during the period and there have been no changes in the related party transactions described in the last Annual Report that could do so.

 

15. Results

The Company's auditor, KPMG LLP, has not audited or reviewed the Interim Report to 30 November 2019 pursuant to the Auditing Practices Board guidance on 'Review of Interim Financial Information'. These are not full statutory financial statements in terms of Section 434 of the Companies Act 2006 and are unaudited. Statutory financial statements for the year ended 31 May 2019, which received an unqualified audit report, and which did not contain a statement under Section 498 of the Companies Act 2006, have been lodged with the Registrar of Companies. The abridged financial statements included for the year ended 31 May 2019 are an extract from those financial statements. No full statutory financial statements in respect of any period after 31 May 2019 have been reported on by the Company's auditor or delivered to the Registrar of Companies. The Interim Report will be posted to shareholders shortly and is available on the website: www.bmomanagedportfolio.com

 

 

Alternative Performance Measures ("APMs")

The Company uses the following APMs:

Discount/premium - the share price of an investment company is derived from buyers and sellers trading their shares on the stock market. This price is not identical to the net asset value (NAV) per share of the underlying assets less liabilities of the Company. If the share price is lower than the NAV per share, the shares are trading at a discount. This usually indicates that there are more sellers of shares than buyers. Shares trading at a price above NAV per share are deemed to be at a premium usually indicating there are more buyers of shares than sellers.

 

 

30 November 2019

31 May 2019

Income shares

Growth shares

Income shares

Growth shares

Net asset value per share

(a)

136.75p

214.62p

131.81p

205.17p

Share price

(b)

137.50p

213.00p

134.50p

206.00p

+Premium/-discount

(c=(b-a)/(a))

 

(c)

 

+0.5%

 

-0.8%

 

+2.0%

 

+0.4%

 

Total return - the return to shareholders calculated on a per share basis by adding dividends paid in the period to the increase or decrease in the share price or NAV in the period. The dividends are assumed to have been re-invested in the form of shares or net assets, respectively, on the date on which the shares were quoted ex-dividend.

The effect of reinvesting these dividends on the respective ex-dividend dates and the share price total returns and NAV total returns are shown below.

 

Six months to

Year to

30 November 2019

31 May 2019

Income shares

Growth shares

Income shares

Growth shares

NAV per share at start of financial period/year

 

131.81p

 

205.17p

 

135.29p

 

206.23p

NAV per share at end of financial period/year

 

136.75p

 

214.62p

 

131.81p

 

205.17p

Change in the period/year

3.7%

4.6%

-2.6%

-0.5%

Impact of dividend reinvestment (1)

2.6%

n/a

5.1%

n/a

NAV total return for the period/year

6.3%

4.6%

2.5%

-0.5%

 

 (1) During the six months to 30 November 2019 dividends totalling 3.30p went ex dividend with respect to the Income shares. During the year to 31 May 2019 the equivalent figure was 6.65p.

 

Six months to 30 November 2019

Year to 31 May 2019

Income shares

Growth shares

Income shares

Growth shares

Share price per share at start of financial period/year

 

134.5p

 

206.0p

 

138.0p

 

209.0p

Share price per share at end of financial period/year

 

137.5p

 

213.0p

 

134.5p

 

206.0p

Change in the period/year

2.2%

3.4%

-2.5%

-1.4%

Impact of dividend reinvestment (1)

 

2.5%

 

n/a

 

5.0%

 

n/a

Share price total return for the period/year

 

4.7%

 

3.4%

 

2.5%

 

-1.4%

 

(1) During the six months to 30 November 2019 dividends totalling 3.3p went ex dividend with respect

to the Income shares. During the year to 31 May 2019 the equivalent figure was 6.65p.

 

Yield - the total annual dividend expressed as a percentage of the period-end share price.

 

30 November 2019

31 May 2019

Annual dividend

(a)

6.10p(1)

5.95p

Income share price

(b)

137.5p

134.5p

Yield (c=a/b)

(c)

4.4%

4.4%

 

(1) Based on dividends at the expected minimum annual rate of 6.10 pence per Income share for the

financial year to 31 May 2020.

 

 

 

 

For further information, please contact:

 

Peter Hewitt, BMO Investment Business Limited 0131 718 1244

Ian Ridge, BMO Investment Business Limited 0131 718 1010

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IR BLGDBIXDDGGS
Date   Source Headline
30th Jun 20221:54 pmRNSChange of Name
30th Jun 202212:50 pmRNSNet Asset Value(s)
29th Jun 202212:57 pmRNSNet Asset Value(s)
28th Jun 20221:05 pmRNSNet Asset Value(s)
27th Jun 20221:18 pmRNSNet Asset Value(s)
24th Jun 20221:27 pmRNSNet Asset Value(s)
23rd Jun 202212:51 pmRNSNet Asset Value(s)
22nd Jun 20224:59 pmRNSIssue of Equity
22nd Jun 20221:07 pmRNSNet Asset Value(s)
21st Jun 202212:55 pmRNSNet Asset Value(s)
20th Jun 20224:08 pmRNSNet Asset Value(s)
17th Jun 20222:37 pmRNSNet Asset Value(s)
16th Jun 20221:11 pmRNSNet Asset Value(s)
15th Jun 20221:05 pmRNSNet Asset Value(s)
14th Jun 20221:04 pmRNSNet Asset Value(s)
13th Jun 202212:54 pmRNSNet Asset Value(s)
10th Jun 20221:48 pmRNSNet Asset Value(s)
9th Jun 202212:55 pmRNSNet Asset Value(s)
9th Jun 202211:58 amRNSDirectorate Change
8th Jun 20224:53 pmRNSPortfolio Update
8th Jun 202212:56 pmRNSNet Asset Value(s)
7th Jun 20221:03 pmRNSNet Asset Value(s)
6th Jun 20222:09 pmRNSNet Asset Value(s)
6th Jun 202211:43 amRNSCompliance with Market Abuse Regulation
1st Jun 20221:15 pmRNSNet Asset Value(s)
31st May 202212:58 pmRNSNet Asset Value(s)
30th May 20221:44 pmRNSNet Asset Value(s)
27th May 202212:59 pmRNSNet Asset Value(s)
26th May 20222:47 pmRNSCancellation of Share Premium Account
26th May 202212:47 pmRNSNet Asset Value(s)
25th May 202212:52 pmRNSNet Asset Value(s)
24th May 20221:06 pmRNSNet Asset Value(s)
23rd May 20221:22 pmRNSNet Asset Value(s)
23rd May 202212:03 pmRNSInvestor Presentation
20th May 202212:56 pmRNSNet Asset Value(s)
19th May 20221:00 pmRNSNet Asset Value(s)
18th May 202212:52 pmRNSNet Asset Value(s)
17th May 20221:06 pmRNSNet Asset Value(s)
16th May 20221:07 pmRNSNet Asset Value(s)
13th May 20222:11 pmRNSPortfolio Update
13th May 20221:13 pmRNSNet Asset Value(s)
12th May 202212:51 pmRNSNet Asset Value(s)
11th May 202212:56 pmRNSNet Asset Value(s)
10th May 20221:04 pmRNSNet Asset Value(s)
9th May 20221:40 pmRNSNet Asset Value(s)
6th May 202212:42 pmRNSNet Asset Value(s)
5th May 202212:53 pmRNSNet Asset Value(s)
4th May 20221:00 pmRNSNet Asset Value(s)
3rd May 20223:49 pmRNSTotal Voting Rights
3rd May 20221:43 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.